載入...
Adjuvant medications that improve survival after locoregional therapy
PURPOSE: To determine if outpatient medications taken at the time of liver tumor embolization or ablation affect survival. METHODS: An IRB-approved retrospective review was performed of 2032 liver tumor embolization, radioembolization, and ablation procedures on 1092 patients from June 2009 to April...
Na minha lista:
| 發表在: | J Vasc Interv Radiol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502720/ https://ncbi.nlm.nih.gov/pubmed/28527884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2017.04.016 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|